Search research articles
Contact Us
Filters
Showing results (11-20 of 52) with videos related to
Page
of 6
Sort By:
Current Drug Targets
|
February 10, 2009
Targeted cancer immunotherapy using ligands of the tumor necrosis factor super-family
E Bremer, M de Bruyn, H Wajant, et al.
Journal of Fish Biology
|
June 10, 2011
Successful extraction of DNA from archived alcohol-fixed white-eye fish specimens using an ancient DNA protocol
M de Bruyn, L R Parenti, G R Carvalho
Archives Internationales De Physiologie Et De Biochimie
|
July 1, 1983
[Modification of the antiradical defense system of the organism under the influence of the administration of a leukocyte factor in the rabbit. Its relation to the increase of radioresistance by biostimulants]
P Van Caneghem, F Stein, M De Bruyn-Dister
AIDS Care
|
January 1, 1994
Evaluation of a home-care/counselling AIDS programme in Kgatleng district, Botswana
P Buwalda, D J Kruijthoff, M de Bruyn, et al.
Physical Review Letters
|
May 31, 2019
Asymptotic Dynamics of High Dynamic Range Stratified Turbulence
G D Portwood, S M de Bruyn Kops, C P Caulfield
Acta Psychiatrica Belgica
|
July 1, 1977
[Late catatonic syndrom symptomatic of a degenerative encephalopathy (author's transl)]
E Evrard, V Molders, A M de Bruyn-Mottard, et al.
Current Drug Targets
|
December 19, 2009
Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncology
B ten Cate, M de Bruyn, Y Wei, et al.
International Review of Cell and Molecular Biology
|
March 23, 2017
Antibody-Based Cancer Therapy: Successful Agents and Novel Approaches
D Hendriks, G Choi, M de Bruyn, et al.
Experientia
|
May 15, 1988
Human myeloperoxidase activity is inhibited in vitro by quercetin. Comparison with three related compounds
J Pincemail, C Deby, A Thirion, et al.
Life Sciences
|
April 4, 2022
NEAT1: Culprit lncRNA linking PIG-C, MSLN, and CD80 in triple-negative breast cancer
Nada H Hussein, Reda A Eissa, M de Bruyn, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 52) with videos related to
Sort By:
Page
of 6
Current Drug Targets
|
February 10, 2009
Targeted cancer immunotherapy using ligands of the tumor necrosis factor super-family
E Bremer, M de Bruyn, H Wajant, et al.
Journal of Fish Biology
|
June 10, 2011
Successful extraction of DNA from archived alcohol-fixed white-eye fish specimens using an ancient DNA protocol
M de Bruyn, L R Parenti, G R Carvalho
Archives Internationales De Physiologie Et De Biochimie
|
July 1, 1983
[Modification of the antiradical defense system of the organism under the influence of the administration of a leukocyte factor in the rabbit. Its relation to the increase of radioresistance by biostimulants]
P Van Caneghem, F Stein, M De Bruyn-Dister
AIDS Care
|
January 1, 1994
Evaluation of a home-care/counselling AIDS programme in Kgatleng district, Botswana
P Buwalda, D J Kruijthoff, M de Bruyn, et al.
Physical Review Letters
|
May 31, 2019
Asymptotic Dynamics of High Dynamic Range Stratified Turbulence
G D Portwood, S M de Bruyn Kops, C P Caulfield
Acta Psychiatrica Belgica
|
July 1, 1977
[Late catatonic syndrom symptomatic of a degenerative encephalopathy (author's transl)]
E Evrard, V Molders, A M de Bruyn-Mottard, et al.
Current Drug Targets
|
December 19, 2009
Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncology
B ten Cate, M de Bruyn, Y Wei, et al.
International Review of Cell and Molecular Biology
|
March 23, 2017
Antibody-Based Cancer Therapy: Successful Agents and Novel Approaches
D Hendriks, G Choi, M de Bruyn, et al.
Experientia
|
May 15, 1988
Human myeloperoxidase activity is inhibited in vitro by quercetin. Comparison with three related compounds
J Pincemail, C Deby, A Thirion, et al.
Life Sciences
|
April 4, 2022
NEAT1: Culprit lncRNA linking PIG-C, MSLN, and CD80 in triple-negative breast cancer
Nada H Hussein, Reda A Eissa, M de Bruyn, et al.
Page
of 6